An engineered riboswitch as a potential gene-regulatory platform for reducing antibacterial drug resistance.
Synthetic riboswitch containing aptamer is constructed in E. coli to regulate the expression of β-lactamase through small molecule-aptamer interactions, which sharply reduces the antibiotic resistance of the engineered bacteria.